Lactosylceramide

Last updated
The structure of lactosylceramide. Lactosylceramid.svg
The structure of lactosylceramide.

The Lactosylceramides, also known as LacCer, are a class of glycosphingolipids composed of a variable hydrophobic ceramide lipid and a hydrophilic sugar moiety. Lactosylceramides are found in microdomains on the plasma layers of numerous cells. Moreover, they are a type of ceramide including lactose, which is an example of a globoside.

Contents

As with many lipids, the chemical formula and molecular weight varies depending on the fatty-acid present. As one example, the chemical formula of Lactosylceramide (d18:1/12:0) is C42H79NO13, which has 806.088 g/mol of molar mass, and the IUPAC name of this species is N-(dodecanoyl)-1-beta-lactosyl-sphing-4-enine. [1]

Lactosylceramides were initially called 'cytolipin H'. It is found in small amounts just in most creature tissues, however, it has various huge organic capacities and it is of extraordinary significance as the biosynthetic forerunner of the greater part of the impartial oligoglycosylceramides, sulfatides and gangliosides. In creature tissues, biosynthesis of lactosylceramide includes expansion of the second monosaccharides unit (galactose) as its nucleotide subsidiary to monoglucosylceramide, catalyzed by a particular beta-1, 4-galactosyltransferase on the lumenal side of the Golgi mechanical assembly. [2]

In creature tissues, the antecedent glucosylceramide is moved by the sphingolipid transport protein FAPP2 to the distal Golgi, where it should initially cross from the cytosolic side of the membrane conceivably by means of the activity of a flippase. Biosynthesis of lactosylceramide then includes expansion of the second monosaccharides unit as its actuated nucleotide subordinate (UDP-galactose) to monoglucosylceramide on the lumenal side of the Golgi apparatus in a response catalyzed by β-1,4-galactosyltransferases of which two are known. The lactosylceramide created can be further glycosylated, or it very well may be moved to the plasma layer essentially by a non-vesicular system that is inadequately seen, however it can't be translocated back to the cytosolic flyer. It is likewise recovered by the catabolism of a considerable lot of the lipids for which it is the biosynthetic antecedent. Erasure of the lactosylceramide synthase by quality focusing on is embryonically deadly. [3]

Associated disorder

Gaucher's disease is a sphingolipidosis described by a particular inadequacy in acidic glucocerebrosidase, which results in abnormal gathering of glucosylceramide essentially inside the lysosome. Gaucher's disease has been associated with instances of leukemia, myeloma, glioblastoma, lung malignancy, and hepatocellular carcinoma, in spite of the fact that the explanations behind the relationship are at present being discussed. [4]

Some suggest that the impacts of Gaucher's disease might be connected to malignant growth, while others ensnare the treatments used to treat Gaucher's illness. This discussion is not completely astounding, as the theories connecting Gaucher's disease with cancer fail to address the roles of ceramide and glucosylceramide in malignant growth science. [4]

Gaucher disease is caused by mutations in GBA1, which encodes the lysosomal catalyst glucocerebrosidase (GCase). GBA1 transformations drive broad gathering of glucosylceramide (GC) in different natural and versatile resistant cells in the spleen, liver, lung and bone marrow, frequently prompting endless irritation. The systems that interface abundance GC to tissue aggravation stay obscure. [5]

See also

Related Research Articles

<span class="mw-page-title-main">Gaucher's disease</span> Medical condition

Gaucher's disease or Gaucher disease (GD) is a genetic disorder in which glucocerebroside accumulates in cells and certain organs. The disorder is characterized by bruising, fatigue, anemia, low blood platelet count and enlargement of the liver and spleen, and is caused by a hereditary deficiency of the enzyme glucocerebrosidase, which acts on glucocerebroside. When the enzyme is defective, glucocerebroside accumulates, particularly in white blood cells and especially in macrophages. Glucocerebroside can collect in the spleen, liver, kidneys, lungs, brain, and bone marrow.

<span class="mw-page-title-main">Glycolipid</span> Class of chemical compounds

Glycolipids are lipids with a carbohydrate attached by a glycosidic (covalent) bond. Their role is to maintain the stability of the cell membrane and to facilitate cellular recognition, which is crucial to the immune response and in the connections that allow cells to connect to one another to form tissues. Glycolipids are found on the surface of all eukaryotic cell membranes, where they extend from the phospholipid bilayer into the extracellular environment.

<span class="mw-page-title-main">Sphingolipid</span> Family of chemical compounds

Sphingolipids are a class of lipids containing a backbone of sphingoid bases, a set of aliphatic amino alcohols that includes sphingosine. They were discovered in brain extracts in the 1870s and were named after the mythological sphinx because of their enigmatic nature. These compounds play important roles in signal transduction and cell recognition. Sphingolipidoses, or disorders of sphingolipid metabolism, have particular impact on neural tissue. A sphingolipid with an R group consisting of a hydrogen atom only is a ceramide. Other common R groups include phosphocholine, yielding a sphingomyelin, and various sugar monomers or dimers, yielding cerebrosides and globosides, respectively. Cerebrosides and globosides are collectively known as glycosphingolipids.

<span class="mw-page-title-main">Sphingomyelin</span>

Sphingomyelin is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath that surrounds some nerve cell axons. It usually consists of phosphocholine and ceramide, or a phosphoethanolamine head group; therefore, sphingomyelins can also be classified as sphingophospholipids. In humans, SPH represents ~85% of all sphingolipids, and typically make up 10–20 mol % of plasma membrane lipids.

Glycosphingolipids are a subtype of glycolipids containing the amino alcohol sphingosine. They may be considered as sphingolipids with an attached carbohydrate. Glycosphingolipids are a group of lipids and are a part of the cell membrane. They consist of a hydrophobic ceramide part and a glycosidically bound carbohydrate part. This oligosaccharide content remains on the outside of the cell membrane where it is important for biological processes such as cell adhesion or cell–cell interactions. Glycosphingolipids play also important role in oncogenesis and ontogenesis.

<span class="mw-page-title-main">Ceramide</span> Family of waxy lipid molecules

Ceramides are a family of waxy lipid molecules. A ceramide is composed of N-acetylsphingosine and a fatty acid. Ceramides are found in high concentrations within the cell membrane of eukaryotic cells, since they are component lipids that make up sphingomyelin, one of the major lipids in the lipid bilayer. Contrary to previous assumptions that ceramides and other sphingolipids found in cell membrane were purely supporting structural elements, ceramide can participate in a variety of cellular signaling: examples include regulating differentiation, proliferation, and programmed cell death (PCD) of cells.

<span class="mw-page-title-main">Cerebroside</span> Lipid classification

Cerebrosides is the common name for a group of glycosphingolipids called monoglycosylceramides which are important components in animal muscle and nerve cell membranes.

<span class="mw-page-title-main">Glucocerebrosidase</span> Mammalian protein found in Homo sapiens

β-Glucocerebrosidase is an enzyme with glucosylceramidase activity that is needed to cleave, by hydrolysis, the beta-glycosidic linkage of the chemical glucocerebroside, an intermediate in glycolipid metabolism that is abundant in cell membranes. It is localized in the lysosome, where it remains associated with the lysosomal membrane. β-Glucocerebrosidase is 497 amino acids in length and has a molecular weight of 59,700 Daltons.

<span class="mw-page-title-main">Glucocerebroside</span>

Glucocerebroside is any of the cerebrosides in which the monosaccharide head group is glucose.

<span class="mw-page-title-main">Lipid signaling</span> Biological signaling using lipid molecules

Lipid signaling, broadly defined, refers to any biological signaling event involving a lipid messenger that binds a protein target, such as a receptor, kinase or phosphatase, which in turn mediate the effects of these lipids on specific cellular responses. Lipid signaling is thought to be qualitatively different from other classical signaling paradigms because lipids can freely diffuse through membranes. One consequence of this is that lipid messengers cannot be stored in vesicles prior to release and so are often biosynthesized "on demand" at their intended site of action. As such, many lipid signaling molecules cannot circulate freely in solution but, rather, exist bound to special carrier proteins in serum.

Lipid metabolism is the synthesis and degradation of lipids in cells, involving the breakdown and storage of fats for energy and the synthesis of structural and functional lipids, such as those involved in the construction of cell membranes. In animals, these fats are obtained from food and are synthesized by the liver. Lipogenesis is the process of synthesizing these fats. The majority of lipids found in the human body from ingesting food are triglycerides and cholesterol. Other types of lipids found in the body are fatty acids and membrane lipids. Lipid metabolism is often considered as the digestion and absorption process of dietary fat; however, there are two sources of fats that organisms can use to obtain energy: from consumed dietary fats and from stored fat. Vertebrates use both sources of fat to produce energy for organs such as the heart to function. Since lipids are hydrophobic molecules, they need to be solubilized before their metabolism can begin. Lipid metabolism often begins with hydrolysis, which occurs with the help of various enzymes in the digestive system. Lipid metabolism also occurs in plants, though the processes differ in some ways when compared to animals. The second step after the hydrolysis is the absorption of the fatty acids into the epithelial cells of the intestinal wall. In the epithelial cells, fatty acids are packaged and transported to the rest of the body.

Palmitoyl-CoA is an acyl-CoA thioester. It is an "activated" form of palmitic acid and can be transported into the mitochondrial matrix by the carnitine shuttle system, and once inside can participate in beta-oxidation. Alternatively, palmitoyl-CoA is used as a substrate in the biosynthesis of sphingosine.

<span class="mw-page-title-main">Glucosylceramidase</span>

In enzymology, a glucosylceramidase (EC 3.2.1.45) is an enzyme that catalyzes the chemical reaction

In enzymology, a 2-hydroxyacylsphingosine 1-beta-galactosyltransferase is an enzyme that catalyzes the chemical reaction

In enzymology, a ganglioside galactosyltransferase is an enzyme that catalyzes the chemical reaction

In enzymology, a lactosylceramide 4-alpha-galactosyltransferase is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">B4GALT1</span> Protein-coding gene in the species Homo sapiens

Beta-1,4-galactosyltransferase 1 is an enzyme that in humans is encoded by the B4GALT1 gene.

<span class="mw-page-title-main">UGT8</span> Protein-coding gene in the species Homo sapiens

2-hydroxyacylsphingosine 1-beta-galactosyltransferase is an enzyme that in humans is encoded by the UGT8 gene.

Glucosylceramide beta-1,4-galactosyltransferase is an enzyme with systematic name UDP-alpha-D-galactose:beta-D-glucosyl-(1<->1)-ceramide 4-beta-D-galactosyltransferase. This enzyme catalyses the following chemical reaction

In enzymology, a ceramide phosphoethanolamine synthase is an enzyme that catalyzes the chemical reaction

References

  1. "Lactosylceramide (d18:1/12:0)". National Center for Biotechnology Information. PubChem Compound Database. Retrieved 13 July 2019.
  2. "Showing metabocard for Lactosylceramide (d18:1/12:0) (HMDB0004866)". Human Metablome Database (HMDB). 2005-04-30. Retrieved 23 May 2019.
  3. William W., Christie (10 January 2019). "Lactosylceramide and non-Acidic Oligoglycosylceramides" . Retrieved 13 July 2019.{{cite journal}}: Cite journal requires |journal= (help)
  4. 1 2 Barth M., Brian; Shanmugavelandy S., Sriram; Tacelosky M., Diana; Kester, Mark; Morad F., Samy A.; Cabot C., Myles (1 January 2014). "Gaucher's Disease and Cancer: a Sphingolipid Perspective". Crit Rev Oncog. 18 (3): 221–34. doi:10.1615/critrevoncog.2013005814. PMC   3604879 . PMID   23510065.
  5. Pandey, MK.; Burrow, TA.; Rani, R.; Martin, LJ.; Witte, D.; Setchell, KD.; Magnusen, AF.; Zhang, W.; Liou, B.; Köhl, J.; Grabowski, GA. (2 March 2017). "Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease". Nature. 543 (7643): 108–112. doi:10.1038/nature21368. PMID   28225753. S2CID   4040507.